Tech Company Financing Transactions
Kira Pharmaceuticals Funding Round
On 11/16/2020, Kira Pharmaceuticals landed $46 million in financing from 6 Dimensions Capital, Qiming Ventures and Quan Capital.
Transaction Overview
Company Name
Announced On
11/16/2020
Transaction Type
Venture Equity
Amount
$46,000,000
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Cambridge, MA 02114
USA
Cambridge, MA 02114
USA
Phone
Undisclosed
Website
Email Address
Overview
Kira Pharmaceuticals is a biotechnology company developing complement-targeted therapies to treat immune-mediated diseases. Enabled by its LOGIC drug discovery platform, the company is committed to advancing first-in-class and best-in-class therapies to transform the lives of patients with complement-driven diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Frederick Beddingfield
Chief Medical Officer
Richard Lee
Co-Founder
Gonghua Pan
VP - Bus. Development
Kathy He
VP - Bus. Development
Dana Zhang
VP - R & D
Wenru Song
Browse more venture capital transactions:
Prev: 11/16/2020: Metagenomi venture capital transaction
Next: 11/16/2020: Popshop Live venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs